INTERNATIONAL MEET ON CELL SCIENCE AND MOLECULAR BIOLOGY

Valencia Valencia, Spain

On behalf of the Organizing committee, it pleasure to cordially invite you, scientists, academicians, young researchers, business delegates and students from all over the world to attend the International Meet […]

IN FOCUS: THR

Welcome to GTNF’s IN FOCUS Series, our free to register online half-day conference which takes place every spring. IN FOCUS explores the big issues, but in more depth. Launched in 2021, the IN FOCUS series has already trained its lens on THR and on Sustainability. In 2023, tobacco harm reduction is once again in the […]

Webinar | “The goal: world free of smoke. Do we use all available tools?”

Web Event

Organised by SCOHRE, the International Association on Smoking Control & Harm Reduction, in collaboration with the Polish Society of Public Health The webinar will focus on three most important issues addressing the use of harm reduction as a possible tool in reducing morbidity: NCDs major risk factors chronic disease economics and taxes as a fiscal tool in […]

Vapitaly 2023

Veronafiere Viale dell’Industria, 36, Verona, VR, Italy

The world’s biggest vaping event. In Verona, from 27 to 29 May 2023. Agreement signed between Vapitaly and the Chinese exhibition IECIE

GFN Warsaw 2023

Warsaw Warsaw, Poland

Are you as excited for #GFN23 as we are? As preparations for this year’s conference in Warsaw (21 - 24 June) intensify, we have a couple of important announcements to make. We know that you’ve been hotly anticipating who will be speaking at #GFN23 - well, without further ado, we are very happy to announce […]

Between risk, prevention, diagnosis, and therapies for dyslipidemias

Bari Bari, Italy

High cholesterol is one of the leading risk factors for cardiovascular disease, as evidenced by multiple epidemiological and intervention studies that have shown a near-linear relationship between this dyslipidemia, morbidity, and cardiovascular mortality. After the forced break due to the SARS-CoV-2 pandemic, it is appropriate to return to discussing "non-communicable chronic diseases" whose health risks […]